EIKO Lifesciences
54.80
+1.30(+2.43%)
Market Cap₹78.67 Cr
PE Ratio15.16
IndustryChemicals
Company Performance:
1D+2.43%
1M+5.28%
6M+0.09%
1Y+7.49%
5Y+12.99%
View Company Insightsright
More news about EIKO Lifesciences
31Oct 25
Eiko Life Sciences Reports 281% Surge in Q2 Profit, Revenue Up 19%
EIKO Lifesciences, a specialty chemicals and pharma intermediates company, announced impressive Q2 FY2026 results. Net profit soared 281% year-on-year to ₹81.76 lakhs, while revenue from operations grew 19% to ₹919.74 lakhs. Earnings per share increased by 275% to ₹0.60. Half-year profit rose 172% to ₹150.98 lakhs. Consolidated results showed even stronger performance with a 43% revenue increase and 356% net profit growth. The Board approved these unaudited results on October 31, 2025.
 no imag found
29Jul 25
Eiko LifeSciences Reports Strong Q1 Results, Announces Board Changes and Capital Increase
Eiko LifeSciences Limited reported its Q1 FY2025-26 results. Consolidated revenue was ₹1,071.15 lakhs, slightly down from ₹1,075.04 lakhs in Q1 last year. However, profit after tax significantly increased to ₹111.74 lakhs from ₹37.13 lakhs. EPS rose to ₹0.66 from ₹0.29. The company announced board changes including the resignation of Mr. Umesh More and appointment of Mr. Sumukh Prabhakar Vartak as Whole Time Director. The board approved an increase in authorized share capital from ₹14 crore to ₹20 crore, subject to shareholder approval. The company operates in specialty chemicals and logistics segments, with the former contributing ₹840.22 lakhs in revenue and the latter ₹230.93 lakhs.
 no imag found
29Jul 25
Eiko LifeSciences Announces Board Changes and Expansion Plans at 48th AGM
Eiko LifeSciences Limited has announced significant board changes including the resignation of Mr. Umesh More and appointment of Mr. Sumukh Prabhakar Vartak as Whole Time Director. The company plans to increase its Authorized Share Capital from Rs. 14 crore to Rs. 20 crore. For Q1 FY 2025-26, the company reported a consolidated net profit of Rs. 111.74 lakhs, up from Rs. 37.13 lakhs in the same quarter last year. The 48th AGM is scheduled for September 5, 2025, where these changes and financial results will be addressed.
 no imag found
EIKO Lifesciences
54.80
+1.30
(+2.43%)
1 Year Returns:+7.49%
Industry Peers
Pidilite Industries
1,340.00
(-3.42%)
SRF
2,499.70
(-4.82%)
Gujarat Fluorochemicals
3,070.60
(-3.60%)
Deepak Nitrite
1,448.40
(-2.17%)
Atul
6,464.00
(+2.56%)
Aarti Industries
420.75
(-5.70%)
BASF
3,463.40
(-0.18%)
Anupam Rasayan
1,235.00
(-2.53%)